BioNTech SE - ADR

NASDAQ:BNTX   3:59:50 PM EDT
104.93
+3.06 (+3.00%)
5:07:19 PM EDT: $104.95 +0.02 (+0.02%)
Products, Regulatory

Shanghai Fosun Pharmaceutical Says Cooperation With BioNtech On COVID-19 Vaccine Advancing In Orderly Manner

Published: 11/10/2020 15:09 GMT
BioNTech SE (BNTX) - Clarification Announcement on Media Reports.
As of Today,cooperation Between Fosun Pharmaceutical Industrial, Biontech on Covid Vaccine Advancing in Orderly Manner.
As of Today, Trials for Other Covid-19 Vaccine Candidates Under License Agreement With Biontech Not Yet Commenced.
Currently Covid-19 Vaccine Candidate Btn162b1 is at Phase I Clinical Trial in Prc (excluding Hk , Macau, Taiwan).